Investigation of menstruation recovery after LH-RH agonist therapy for premenopausal patients with breast cancer

Breast Cancer

Volumn 7, Issue 3, 2000, Pages 237-240

  Matsumoto, Masanari ^a   Miyauchi, Mitsuru ^a   Yamamoto, Naohito ^a   Shishikura, Tomotane ^a   Imanaka, Nobuhiro ^a  

^a CHIBA CANCER CENTER   (Japan)

Author keywords

Breast cancer; LH RH agonist; Menstruation recovery; Premenopausal patients

Indexed keywords

ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; GONADORELIN; GOSERELIN;

ADJUVANT CHEMOTHERAPY; ADULT; AGE; ARTICLE; BREAST TUMOR; CONVALESCENCE; DRUG EFFECT; DRUG POTENTIATION; FEMALE; FOLLOW UP; HUMAN; JAPAN; MENSTRUATION; MIDDLE AGED; PATHOLOGY; PREMENOPAUSE; TIME; TREATMENT OUTCOME;

ADULT; AGE FACTORS; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; FOLLOW-UP STUDIES; GONADOTROPIN-RELEASING HORMONE; GOSERELIN; HUMANS; JAPAN; MENSTRUATION; MIDDLE AGED; PREMENOPAUSE; RECOVERY OF FUNCTION; TIME FACTORS; TREATMENT OUTCOME;

EID: 0034566336     PISSN: 13406868     EISSN: 18804233     Source Type: Journal    
DOI: 10.1007/BF02967466     Document Type: Article

References (10)

1. Blamey RW, Jonat W, Kaufmann M, et al: Goserelin depot in the treatment of premenopasal advanced breast cancer. Eur J Cancer 28A(4/5):810-814, 1992.
2. Early Breast Cancer Trialists' Collaborative Group: Ovarian ablation in early breast cancer: overview of the randomized trials. Lancet 348:1189-1196, 1996.
3. Pagani O, O'Neill A, Casfiglione M, et al: Prognostic impact of amenorrhea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement: results of the International Breast Cancer Study Group (IBCSG) Trial VI. Eur J Cancer 34: 632-640, 1998.
4. Goldrisch A, Glick JH, Gelber RD, et al: Meeting highlights: International consensus panel on the treatment of primary breast cancer. J Natl Cancer Inst 90:1601-1608, 1998. (Pubitemid 28523434)
5. Taylor CW, Green S, Dalton WS, et al: Multicenter randomized clinical trial of goserelin versus surgical ovarectomy in premenopausal patients with receptorpositive metastatic breast cancer: an intergroup study.J Clin Oncol 16:994-999, 1998. (Pubitemid 28108732)
6. Muttler L: Experience with a depot GnRH-agonist (Zoladex) in the treatment of genital endometriosis. Hum Reprod 6:694-698, 1991.
7. Reichel RP: Goserelin(Zoladex R) depot in the treatment of endometriosis. Fertil Steril 57: 1197-1202, 1992.
8. West CP, Lumsden MA, Lawson S, et al: Shrinkage of uterine fibroids during therapy with goserelin (Zoladex): a luteinizing hormone-releasing hormone agonist administered as a monthly subcutaneous depot. Fertil Steri1 48:45-51, 1987. (Pubitemid 17093251)
9. Williamson K, Robertson JF, Ellis IO, et al: Effect of LHRH agonist, Zoladex, on ovarian histology. Br J Surg 75:595-596, 1988.
10. Tominaga T: New devlopements in hormonal therapy for breast cancer. Jpn J Cancer Chemother 23: 678-683, May, 1996. (Pubitemid 26190076)